References
- Eltchaninoff H , TronC, CribierA . Percutaneous implantation of aortic valve prosthesis in patients with calcific aortic stenosis: technical aspects . J. Interv. Cardiol.16, 515 – 521 ( 2003 )
- Webb JG , PasupatiS, HumphriesKet al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis . Circulation116, 755 – 763 ( 2007 )
- Grube E , LabordeJC, GerckensUet al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study . Circulation114, 1616 – 1624 ( 2006 )
- Adams DH , PopmaJJ, ReardonMJet al. for the U.S. CoreValve Clinical Investigators . Transcatheter aortic-valve replacement with a self-expanding prosthesis . N. Engl. J. Med.370, 1790 – 1798 ( 2014 )
- Leon MB , SmithCR, MackMet al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery . N. Engl. J. Med.363, 1597 – 1607 ( 2010 )
- Smith CR , LeonMB, MackMJet al. Transcatheter versus surgical aortic-valve replacement in high-risk patients . N. Engl. J. Med.364, 2187 – 2198 ( 2011 )
- Makkar RR , FontanaGP, JilaihawiHet al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis . N. Engl. J. Med.366, 1696 – 1704 ( 2012 )
- Reardon MJ , Van MieghemNM, PopmaJJet al. for the SURTAVI Investigators . Surgical or transcatheter aortic-valve replacement in intermediaterisk patients . N. Engl. J. Med.376, 1321 – 1331 ( 2017 )
- Leon MB , SmithCR, MackMJet al. for the PARTNER 2 Investigators . Transcatheter or surgical aortic-valve replacement in intermediate-risk patients . N. Engl. J. Med.374, 1609 – 1620 ( 2016 )
- Wijeysundera HC , QiuF, KohMet al. Comparison of outcomes of balloon-expandable versus self-expandable transcatheter heart valves for severe aortic stenosis . Am. J. Cardiol.119, 1094 – 1099 ( 2017 )
- Abdel-Wahab M , MehilliJ, FrerkerCet al. ; for the CHOICE Investigators . Comparison of balloon expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial . JAMA31, 1503 – 1514 ( 2014 )
- Ribeiro H , UrenaM, KuckKH, WebbJG, Rodés-CabauJ . Edwards CENTERA valve . EuroIntervention8 ( Suppl. Q ), 79 – 82 ( 2012 ).
- Reichenspurner H , SchaeferA, SchaferUet al. Self-Expanding Transcatheter Aortic Valve System for Symptomatic High Risk Patients With Severe Aortic Stenosis . JACC70, 3127 – 3136 ( 2017 )
- Reichenspurner H . One-year outcomes of CENTERA-EU trial assessing a novel self-expanding transcatheter heart valve . 2018 presentation EUROPCR, Paris, France, May 2018 .
- Manoharan G , WaltonAS, BreckerSJet al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system . J. Am. Coll. Cardiol. Intv.8, 1359 – 1367 ( 2015 )
- Nombela-Franco L , RuelM, RadhakrishnanSet al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis . Am. J. Cardiol.111, 1026 – 1033 ( 2016 )
- Kim U , WindeckerS, KaselAMet al. Computed tomography based oversizing and incidence of para-valvular aortic regurgitation and permanent pacemaker implantation with a new generation self-expanding transcatheter heart valve . Eurointervention14 ( 5 ), e511 – e518 ( 2018 ).
- Williams M , QiaoH, ForrestJ . 1 year outcomes with the Evolut Pro self-expanding repositionable transcatheter aortic valve with pericardial wrap . JACC71 ( 11 Suppl. ), 1142 ( 2018 ).
- Wendler O , SchymikG, TreedeHet al. SOURCE 3: 1 year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve . Eur. Heart J.38 ( 36 ), 2717 – 2726 ( 2017 )